Wendy L. Dixon - Insider Trading & Ownership

Entity
Individual
Summary
The estimated net worth of Wendy L. Dixon is at least $3.48M dollars as of May 15, 2024. Wendy L. Dixon is the Director of Alkermes plc. and owns shares of Alkermes plc. (ALKS) stock worth about $1.37M. Wendy L. Dixon is the Director of INCYTE CORP and owns shares of INCYTE CORP (INCY) stock worth about $1.09M. Wendy L. Dixon is the Director of IOVANCE BIOTHERAPEUTICS, INC. and owns shares of IOVANCE BIOTHERAPEUTICS, INC. (IOVA) stock worth about $469K. Wendy L. Dixon is the Director of ARVINAS, INC. and owns shares of ARVINAS, INC. (ARVN) stock worth about $351K. Wendy L. Dixon is the Director of Black Diamond Therapeutics, Inc. and owns shares of Black Diamond Therapeutics, Inc. (BDTX) stock worth about $173K. Wendy L. Dixon is the Director of bluebird bio, Inc. and owns shares of bluebird bio, Inc. (BLUE) stock worth about $17K.
All Insider Reports
All Insider Reports

Ownership of Wendy L. Dixon

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALKS Alkermes plc. Director $1.37M Jun 14, 2022
INCY INCYTE CORP Director $1.09M Mar 31, 2022
IOVA IOVANCE BIOTHERAPEUTICS, INC. Director $469K Jun 10, 2022
ARVN ARVINAS, INC. Director $351K Jun 15, 2023
BDTX Black Diamond Therapeutics, Inc. Director $173K Mar 15, 2024
BLUE bluebird bio, Inc. Director $17K Nov 11, 2021
ZVRA ZEVRA THERAPEUTICS, INC. Director May 13, 2024

Insider Transactions Reported by Wendy L. Dixon:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.